🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Beautiful outbreak management through testing & tracing, yielding also new insights into the value of backward contact tracing = health & scientific impact combined! 👏🏼 👏🏼

What a day! Representing KU Leuven in Berlin by presenting our #uptider program. First results coming soon 👊🏼 #ScienceReunitesUs

Our #LTBCR lab finally has a website: ltbcr.be ! You are welcome to discover our research on #breastcancer and get to know the members of the team! #bcsm Department of Oncology - KU Leuven Leuven Kankerinstituut

Fully funded 4 year position for a young, motivated PhD candidate from Ukraine now available in KU Leuven‘s Lab. of Experimental Oncology! Interested in testing novel anticancer agents in patient-derived sarcoma mouse models? Get in touch, we are here to help in difficult times!

Our review on ILC is out in Annals of Oncology! Focused research much needed & underway ELBCC Christine Desmedt KarenVanBaelen

Out today: our work showing interruptions in anticancer treatments at time of SARS-CoV2 infection are not associated w/ reduced COVID-related mortality in pts w/ solid cancer -> continue wherever possible! 🙏🏼 Evandro de Azambuja, MD, PhD Kevin Punie Mariana Brandao doi.org/10.1016/j.esmo…

Presented today @ #SABCS22 by the fantastic Sara Tolaney: our work assessing ~25 mets/pt shows intra-patient inter-metastases heterogeneity of HER2-low status ➡️ assessment on a single biopsy might not be representative! Huge milestone for the #UPTIDER tissue donation team!!

Thank you Paolo Tarantino!! Very proud of our work! Christine Desmedt

Got to meet some of the smart 🇧🇪 minds behind the HER2-low autopsy work. Go meet them and learn about their awesome ctDNA work at Poster P5-05-06!

Tatjana Geukens is presenting the latest results of the #UPTIDER post-mortem tissue donation program at #SABCS22 P6-14-14. Happy to contribute to this unique research Christine Desmedt SABCS

Together with my team, we wish you all the best for this new year to come!🌟We will be ready in 2023 to pursue our research together with and for patients with breast cancer.

Ready to make a difference in healthcare in 2023? As a nurse or physician, you can do it with Rotayo! Join our community and find opportunities to learn abroad, plus get the resources you need to succeed. #international #globalhealth ESNO - The European Specialist Nurses community.

Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer 📌HER-Low and HER2-zero are present together in 80% of patients 📌Incompatibility is quite high even in different sampling sites of the same metastasis ❓️How should we identify

This is a problem. Seems with the magnitude of benefit we see with #TDXd, it would be hard to deny someone the possibility of trying T-DXd based on a single biopsy in time. #heterogeneity

Thanks for highlighting our findings ASCP!! Well interpreted by the respondents 👌🏽 Maxim De Schepper Christine Desmedt

Our work on collecting real-world data internationally in challenging times - providing lots of ideas for the future! Kudos to Luis Castelo-Branco (MD; PharmD; PhD) and the whole onco family working on this 👌🏽

Thanks for having me in your fantastic team Sherene Loi, MD!! 🥰

My last day in the lab of Christine Desmedt!! What a beautiful PhD, amazing 4 years, wonderful team effort it's been ☺️ Thanks for everything, my heart is full, can't wait for the clinical & scientific adventures ahead ❤️

#ESMO23 Excellent discussion by ⁦Giampaolo Bianchini⁩ of proffered paper session in met #breastcancer highlighting pivotal findings and clinical relevance from #Uptider regarding temporal and spatial heterogeneity in her2 low status ⁦Tatjana Geukens⁩ ⁦Christine Desmedt⁩